Liu, Y.-S.;                     Wang, J.-X.;                     Jin, G.-Y.;                     Hu, M.-H.;                     Wang, X.-D.    
        Combination Therapy with a TLR7 Agonist and a BRD4 Inhibitor Suppresses Tumor Growth via Enhanced Immunomodulation. Int. J. Mol. Sci. 2024, 25, 663.
    https://doi.org/10.3390/ijms25010663
    AMA Style
    
                                Liu Y-S,                                 Wang J-X,                                 Jin G-Y,                                 Hu M-H,                                 Wang X-D.        
                Combination Therapy with a TLR7 Agonist and a BRD4 Inhibitor Suppresses Tumor Growth via Enhanced Immunomodulation. International Journal of Molecular Sciences. 2024; 25(1):663.
        https://doi.org/10.3390/ijms25010663
    
    Chicago/Turabian Style
    
                                Liu, Yong-Si,                                 Jia-Xin Wang,                                 Guang-Yi Jin,                                 Ming-Hao Hu,                                 and Xiao-Dong Wang.        
                2024. "Combination Therapy with a TLR7 Agonist and a BRD4 Inhibitor Suppresses Tumor Growth via Enhanced Immunomodulation" International Journal of Molecular Sciences 25, no. 1: 663.
        https://doi.org/10.3390/ijms25010663
    
    APA Style
    
                                Liu, Y.-S.,                                 Wang, J.-X.,                                 Jin, G.-Y.,                                 Hu, M.-H.,                                 & Wang, X.-D.        
        
        (2024). Combination Therapy with a TLR7 Agonist and a BRD4 Inhibitor Suppresses Tumor Growth via Enhanced Immunomodulation. International Journal of Molecular Sciences, 25(1), 663.
        https://doi.org/10.3390/ijms25010663